Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Earnings for Sanofi India Limited (SANOFI.NS)
Earnings in 2023 (TTM): $100.13 M
According to Sanofi India Limited's latest financial reports the company's current earnings (TTM) are $100.13 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Sanofi India Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $100.13 M | $71.4 M |
| 2022 | $102.36 M | $73.5 M |
| 2021 | $148.94 M | $111.85 M |
| 2020 | $80.2 M | $56.56 M |
| 2019 | $71.05 M | $49.05 M |
| 2018 | $72.22 M | $45.07 M |
| 2017 | $60.94 M | $38.61 M |
| 2016 | $55.2 M | $35.17 M |
| 2015 | $47.02 M | $38.07 M |
| 2014 | $36.25 M | $31.22 M |
| 2013 | $43 M | $31.41 M |
| 2012 | $30.99 M | $20.92 M |
| 2011 | $33.63 M | $22.64 M |
| 2010 | $27.71 M | $18.36 M |
| 2009 | $28.6 M | $18.64 M |
| 2008 | $30.75 M | $19.68 M |
| 2007 | $26.39 M | $17.1 M |
| 2006 | $29.57 M | $20.05 M |
| 2005 | $28 M | $17.18 M |
| 2004 | $26.79 M | $17.59 M |